WORK WITH A CRO THAT UNDERSTANDS YOUR RARE PATIENT POPULATION
Worldwide Clinical Trials has extensive experience in rare disease and pulmonary arterial hypertension (PAH) trials, which is derived from our global PAH trial experience and enhanced by our medical and scientific understanding of unique PAH trial requirements.
But a successful PAH trial requires much more than scientific expertise. With rare diseases such as PAH, it’s important to consider the day-to-day perspectives and needs of the patient to make their clinical trial participation a positive experience and retain them throughout the duration of the study. PAH patients have certain limitations that Worldwide Clinical Trials recommends evaluating when designing your study.